Clinical trial
To Evaluate Long-Term Safety and Efficacy of Pregabalin in the Treatment of…
NCT00141375 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00141375 |
|---|---|
| Title | To Evaluate Long-Term Safety and Efficacy of Pregabalin in the Treatment of Neuropathic Pain After Spinal Cord Injury. |
| Official title | An Open-Label Extension to Evaluate the Safety and Efficacy of Pregabalin for Treatment of Chronic Central Neuropathic Pain After Spinal Cord Injury. |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Neuropathic Pain |
| Intervention type | Drug |
| Interventions | Pregabalin |
| Enrollment | 132 |
| Start date | Aug 1, 2002 |
| Completion | Jan 1, 2006 |
| First posted | Sep 1, 2005 |
| Last update posted | Jan 15, 2008 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: